BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30030914)

  • 21. Expression level and diagnostic value of exosomal NEAT1/miR-204/MMP-9 in acute ST-segment elevation myocardial infarction.
    Chen Z; Yan Y; Wu J; Qi C; Liu J; Wang J
    IUBMB Life; 2020 Nov; 72(11):2499-2507. PubMed ID: 32916037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.
    Bukauskas T; Mickus R; Cereskevicius D; Macas A
    Med Sci Monit; 2019 May; 25():3925-3932. PubMed ID: 31130720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction.
    Park HJ; Noh JH; Eun JW; Koh YS; Seo SM; Park WS; Lee JY; Chang K; Seung KB; Kim PJ; Nam SW
    Oncotarget; 2015 May; 6(15):12970-83. PubMed ID: 26025919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
    Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.
    Hou LL; Gao C; Feng J; Chen ZF; Zhang J; Jiang YJ; Li XX; Wang BN
    Tohoku J Exp Med; 2017 May; 242(1):27-35. PubMed ID: 28496014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction.
    Balta S; Celik T; Ozturk C; Kaya MG; Aparci M; Yildirim AO; Demir M; Kilic S; Aydin İ; Iyisoy A
    Am J Emerg Med; 2016 Aug; 34(8):1542-7. PubMed ID: 27238848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction.
    Reinstadler SJ; Klug G; Feistritzer HJ; Kofler M; Pernter B; Göbel G; Henninger B; Müller S; Franz WM; Metzler B
    Eur Heart J Cardiovasc Imaging; 2016 Feb; 17(2):169-76. PubMed ID: 26056134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
    Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
    Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of thermodilution-derived coronary blood flow patterns after percutaneous coronary intervention on mid-term left ventricular remodeling in patients with ST elevation myocardial infarction.
    Sumiyoshi A; Fujii K; Fukunaga M; Shibuya M; Imanaka T; Kawai K; Miki K; Tamaru H; Horimatsu T; Saita T; Nishimura M; Masuyama T; Ishihara M
    Heart Vessels; 2017 Jan; 32(1):1-7. PubMed ID: 27048558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI.
    Liu X; Hu Y; Huang W; Zhang G; Cao S; Yan X; Li L; Zhang L; Zheng X
    Int Heart J; 2019 Jan; 60(1):19-26. PubMed ID: 30464124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI.
    Tang C; Luo E; Wang D; Yan G; Qiao Y; Zhu B; Liu B; Hou J
    Biomed Res Int; 2019; 2019():8534752. PubMed ID: 31428649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for ST-segment elevation myocardial infarction.
    Çiçek G; Açıkgöz SK; Yayla Ç; Kundi H; İleri M
    Cardiol J; 2016; 23(3):225-35. PubMed ID: 26779969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Bolat I; Akgul O; Cakmak HA; Pusuroglu H; Somuncu U; Ozbey S; Ornek V; Erturk M; Gul M
    Kardiol Pol; 2016; 74(4):346-55. PubMed ID: 26365942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
    Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
    Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
    J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.